GH1 and Insulin resistance: Definitive evidence of the role of FFAs in GH-mediated insulin resistance was obtained in clinical studies in which the effects of exogenously administered GH on insulin resistance were abrogated by AcipimoxTM—an inhibitor of lipolysis [185, 190, 191].